Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TheraGenesis is a regenerative medicine company focused on developing advanced therapies for wound healing and tissue repair. The company's core technology involves a proprietary platform that utilizes autologous cell-based therapies and advanced biologics to treat chronic and acute wounds, such as diabetic foot ulcers and severe burns. By leveraging the body's natural healing mechanisms, TheraGenesis aims to provide more effective and faster-acting solutions than traditional wound care methods. Their approach integrates specialized delivery systems with biological components to optimize the regenerative environment at the site of injury.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TheraGenesis.